Fibrolamellar Carcinoma of the Liver

  • Donald B. Rolfes


Hepatocellular carcinoma (HCC) usually develops in cirrhotic livers of older adults. Typically, it is widely disseminated or multicentric at the time of diagnosis, unresectable, and has a poor prognosis with survival time measured in months. Fibrolamellar carcinoma (FLC) is a variant of HCC whose separation as a distinct entity is justified by clinicopathological features which sharply contrast with those commonly observed in HCC (Table 10.1). FLC occurs in children and young adults with noncirrhotic livers and has unique histological features from which its name derives. Edmondson first recognized these characteristics in a case he described in 1956 [1], and this was followed by the report of five additional cases by Peters in 1976, who referred to them as HCC with lamellar fibrosis [2]. The existence of this neoplasm was subsequently confirmed by two large series in 1980: In the series of Berman et al. [3] the term HCC of poly-gonal cell type with lamellar fibrosis was used; the other series was by Craig et al. [4], whose term FLC of the liver has persisted. While this neoplasm constitutes only l%–2% of all HCC [5], 40% of cases seen in patients under 35 years of age are of this type [6]. At the time of diagnosis, the tumor is frequently localized in the liver, surgically resectable, and potentially curable. The recognition of FLC is consequently of major importance.


Hepatocellular Carcinoma Focal Nodular Hyperplasia Alpha Fetoprotein Tocellular Carcinoma Endodermal Sinus Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Edmondson HA (1956) Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. Arch Dis Child 1:168–186Google Scholar
  2. 2.
    Peters RL (1976) Pathology of hepatocellular carcinoma. In: Okuda K, Peters RL (eds) Hepatocellular carcinoma. Wiley, New York, p 107Google Scholar
  3. 3.
    Berman MM, Libbey NP, Foster JH (1980) Hepatocellular carcinoma. Polygonal cell type with fibrous stroma—an atypical variant with a favorable prognosis. Cancer 46:1448–1455CrossRefPubMedGoogle Scholar
  4. 4.
    Craig JR, Peters RL, Edmondson HA, Omata M (1980) Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinicopathologic features. Cancer 46: 372–379CrossRefPubMedGoogle Scholar
  5. 5.
    Craig JR, Van Thiel DH (1985) Fibrolamellar carcinoma. In: Ishak KG (ed) Hepatopathology 1985. Syllabus of the postgraduate course of the American Association for the Study of Liver Disease, 3–4 Nov. 1985, Chicago. Available from Slack Inc. Thorocare, New Jersey 08086, pp 361-371Google Scholar
  6. 6.
    Farhi DC, Shikes RH, Murari PJ, Silverberg SG (1983) Hepatocellular carcinoma in young people. Cancer 52:1516–1525CrossRefPubMedGoogle Scholar
  7. 7.
    Goodman ZD, Ishak KG (1982) Hepatocellular carcinoma in women: probable lack of etiologic association with oral contraceptive steroids. Hepatology 2:440–444CrossRefPubMedGoogle Scholar
  8. 8.
    Paradinas FJ, Melia WM, Wilkinson ML, Portmann B, Johnson PJ, Murray-Lyon IM, Williams R (1982) High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J 285:840–842CrossRefGoogle Scholar
  9. 9.
    Collier NA, Bloom SR, Hodgson HJF, Weinbren K, Lee YC, Blumgart LH (1984): Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet 1:538–540CrossRefPubMedGoogle Scholar
  10. 10.
    Teitelbaum DH, Tuttle S, Carey LC, Clausen KP (1985) Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. Ann Surg 202: 36–41CrossRefPubMedGoogle Scholar
  11. 11.
    Wood JR, Melia WM, Wood SM, Wilkinson ML, Lee YC, Portmann B, Bloom SR, Williams R (1984) Neurotensin and hepatocellular carcinoma (Letter to the editor). Lancet 1:687CrossRefPubMedGoogle Scholar
  12. 12.
    Friedman AC, Lichtenstein JE, Goodman ZD, Fishman EK, Siegelman SS, Dachman AH (1985) Fibrolamellar hepatocellular carcinoma. Radiology 157:583–587PubMedGoogle Scholar
  13. 13.
    Francis IR, Agha FP, Thompson NW, Keren DF (1986) Fibrolamellar hepatocarcinoma: clinical, radiologic and pathologic features. Gastrointest Radiol 11:67–72CrossRefPubMedGoogle Scholar
  14. 14.
    Wong LK, Link DP, Frey CF, Ruebner BH, Tesluk H, Pimstone NR (1982) Fibrolamellar hepatocarcinoma: radiology, management and pathology AJR 139:172–175CrossRefPubMedGoogle Scholar
  15. 15.
    Vecchio FM, Fabiano A, Ghirlanda G, Manna R, Massi G (1984) Fibrolamellar carcinoma of the liver: the malignant counterpart of focal nodular hyperplasia with oncocytic change. Am J Clin Pathol 81: 521–526PubMedGoogle Scholar
  16. 16.
    Prat J, Bhan AK, Dickersin GR, Robboy SJ, Scully RE (1982) Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation). A light microscopic, ultrastructural and immunohistochemical study of seven cases. Can-cer 50:2355–2368Google Scholar
  17. 17.
    Caballero T, Aneiros J, Lopez-Caballero J, Gomez-Morales M, Nogales F (1985): Fibrolamellar hepatocellular carcinoma. An immunohistochemical and ultrastructural study. Histopathology 9:445–456CrossRefPubMedGoogle Scholar
  18. 18.
    Lefkowitch JH, Muschel R, Price JB, Marboe C, Braunhut S (1983) Copper and copper-binding protein in fibrolamellar liver cell carcinoma. Cancer 51:97–100CrossRefPubMedGoogle Scholar
  19. 19.
    Stromeyer FW, Ishak KG, Gerber MA, Mathew T (1980) Ground-glass cells in hepatocellular carcinoma. Am J Clin Pathol 74:254–258PubMedGoogle Scholar
  20. 20.
    Sheahan DG (1986) Fibrolamellar carcinoma of the liver: an immunohistochemical study (abstract) Lab Invest 54: 57AGoogle Scholar
  21. 21.
    Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L (1985) Combined hepatocellular-cholangiocellular carcinoma. A histologic and immunohistologic study. Cancer 55:124–135CrossRefPubMedGoogle Scholar
  22. 22.
    Nagorney DM, Adson MA, Weiland LH, Knight CD, Smalley SR, Zinsmeister AR (1985) Fibrolamellar hepatoma. Am J Surg 149:113–119CrossRefPubMedGoogle Scholar
  23. 23.
    An T, Ghatak N, Kastner R, Kay S, Lee HM (1983) Hyaline globules and intracellular lumina in a hepatocellular carcinoma. Am J Clin Pathol 79:392–396PubMedGoogle Scholar
  24. 24.
    Baithun SI, Pollock DJ (1983) Oncocytic hepatocellular tumor. Histopathology 7:107–112CrossRefPubMedGoogle Scholar
  25. 25.
    Farhi DC, Shikes RH, Silverberg SG (1982) Ultrastructure of fibrolamellar oncocytic hepatoma. Cancer 50:702–709CrossRefPubMedGoogle Scholar
  26. 26.
    Mierau GW, Orsini EN (1983) Case for diagnosis. Ultrastruct Pathol 5:273–279CrossRefPubMedGoogle Scholar
  27. 27.
    Jagirdar J, Ishak KG, Colombo M, Brambilla C, Paronetto F (1985) Fibronectin patterns in hepatocellular carcinoma and its clinical significance. Cancer 56:1643–1648CrossRefPubMedGoogle Scholar
  28. 28.
    Lack EE, Neave C, Vawter GF (1983) Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 52:1510–1515CrossRefPubMedGoogle Scholar
  29. 29.
    Starzl TE, Iwatsuki S, Shaw BW, Nalesnik MA, Farhi DC, Van Thiel DH (1986) Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 162:145–148PubMedGoogle Scholar
  30. 30.
    Ihde DC, Matthews MJ, Makuch RW, McIntire KR, Eddy JL, Seeff LB (1985) Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival. Am J Med 78:399–406CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan 1987

Authors and Affiliations

  • Donald B. Rolfes
    • 1
  1. 1.Department of Hepatic PathologyArmed Forces Institute of PathologyUSA

Personalised recommendations